Severe atherosclerosis in rheumatoid arthritis and hyperhomocysteinemia: Is there a link?

Joint Bone Spine

Volumn 75, Issue 4, 2008, Pages 499-501

  El Bouchti, Imane ^a   Sordet, Christelle ^a   Kuntz, Jean Louis ^a   Sibilia, Jean ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Atheroma; Hyperhomocysteinemia; Rheumatoid arthritis

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; CYANOCOBALAMIN; FOLIC ACID; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; METHYLENETETRAHYDROFOLIC ACID; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; AGING; ARTERY DISEASE; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE REPORT; CHRONIC INFLAMMATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; LOW DRUG DOSE; MORBIDITY; MORTALITY; MTHFR GENE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; VASCULITIS; VITAMIN DEFICIENCY;

ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 46449097698     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.07.022     Document Type: Article

References (14)

1. Pham T., Gossec L., Constantin A., et al. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 73 (2006) 379-387
2. Gonzalez-Gay M.A., Gonzalez-Juanatey C., and Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35 (2005) 8-17
3. Meyer O. Atherosclerosis and connective tissue diseases. Joint Bone Spine 68 (2001) 564-575
4. Soubrier M., and Dougados M. Athérome et polyarthrite rhumatoïde. Rev Med Interne 27 (2006) 125-136
5. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocysteinemia is a risk factor for occlusive vascular disease. Annu Rev Nutr 12 (1992) 279-298
6. Lopez-Olivo M.A., Gonzalez-Lopez L., Garcia-Gonzalez A., et al. Factors associated with hyperhomocysteinemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35 (2006) 112-116
7. Berrut G., Ghali A., Querre I., et al. La mutation C677T du gène de la 5,10-méthyltétrahydrofolate réductase est associée aux thromboses veineuses idiopathiques. Rev Med Interne 24 (2003) 569-576
8. Schroecksnadel K., Frick B., Kaser S., et al. Moderate hyperhomocysteinemia and immune activation in patients with rheumatoid arthritis. Clin Chim Acta 338 (2003) 157-164
9. Del Rincon I.D., Williams K., Stern M.P., et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44 (2001) 2737-2745
10. Lazzerini P.E., Selvi E., Lorenzini S., et al. Homocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 24 (2006) 387-393
11. Sherer Y., Gerli R., Vaudo G., et al. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Ann N Y Acad Sci 1051 (2005) 299-303
12. Pahor A., Hojs R., Holc I., et al. Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis. Immunobiology 211 (2006) 689-694
13. Seriolo B., Fasciolo D., Sulli A., et al. Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events. Clin Exp Rheumatol 19 (2001) 561-564
14. Sibilia J., Hercelin D., Gottenberg J.E., et al. Cervico-cranial artery dissection and antiphospholipid syndrome: is there a link?. Am J Med 116 (2004) 138-139